Survival analysis | ||||
---|---|---|---|---|
Variable | Univariate | Multivariate | ||
HR (95 % CI) | P | HR (95 % CI) | P | |
Age | 1.106 (0.895-1.367) | 0.351 | Â | Â |
Tumor primary site | 0.337(0.045-2.533) | 0.291 | Â | Â |
MYCN | 1.492(0.605-3.680) | 0.385 | Â | Â |
1p | 1.202(0.794-1.820) | 0.384 | Â | Â |
11q | 1.529(1.035-2.259) | 0.033* | Â | 0.359 |
INSS stage | 3.508(0.922-13.551) | 0.066 | Â | Â |
COG group | 4.719(1.474-15.113) | 0.009* | Â | 0.125 |
NSE | 1.000(1.000-1.001) | 0.256 | Â | Â |
LDH | 1.000(1.000-1.001) | 0.336 | Â | Â |
PHOX2B | 1.000(1.000-1.001) | 0.212 | Â | Â |
BMI | 6.336(1.426-28.153) | 0.015* | 4.677(1.032-21.205) | 0.045* |
SUVmean | 0.981(0.644-1.493) | 0.928 | Â | Â |
SUVmax | 1.083(0.949-1.237) | 0.237 | Â | Â |
SUVpeak | 1.085(0.912-1.290) | 0.358 | Â | Â |
MTVtotal | 1.000(0.999-1.002) | 0.615 | Â | Â |
MTV40% | 1.000(0.997-1.003) | 0.9 | Â | Â |
TLGtotal | 1.000(0.999-1.001) | 0.918 | Â | Â |
TLG40% | 1.000(0.999-1.001) | 0.804 | Â | Â |
AUC-CSHtotal | 0.001(0.001-0.164) | 0.007* | 0.005(0.000-0.705) | 0.036* |
AUC-CSH40% | 0.001(0.001-1.103) | 0.052 | Â | Â |